60P Baseline characteristics and molecular testing of patients with IDH1-mutated cholangiocarcinoma: Initial results from the phase IIIb ProvIDHe study
Autor: | Rimassa, L., Bridgewater, J.A., Gardini, A. Casadei, Wilmink, H., Sim, H-W., de Vos-Geelen, J., Mercade, T. Macarulla, Malka, D., Gharbi, H., Robert, R., Sullivan, A., Vogel, A. |
---|---|
Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S236-S236 |
Databáze: | ScienceDirect |
Externí odkaz: |